Skip to main content
. Author manuscript; available in PMC: 2020 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):475–482. doi: 10.1097/QAI.0000000000002183

Figure 1.

Figure 1.

Both BZD+ groups (i.e., BZD+/TOX− and BZD+/TOX+) exhibited poorer neurocognition than the BZD− reference group. Estimates reflect each BZD+ group minus the BZD− reference group such that lower effect sizes indicate that the BZD+ group has lower T-scores for that domain. Statistically significant differences (i.e., p < 0.05) exist when the 95% confidence interval bars do not cross the dashed horizontal line (i.e., Cohen’s d = 0).